Hillsdale Investment Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-80
Closed -$6.55K 628
2024
Q3
$6.55K Hold
80
﹤0.01% 557
2024
Q2
$6.9K Hold
80
﹤0.01% 512
2024
Q1
$6.53K Hold
80
﹤0.01% 522
2023
Q4
$5.3K Sell
80
-10
-11% -$693 ﹤0.01% 532
2023
Q3
$6.58K Buy
90
+30
+50% +$2.03K ﹤0.01% 461
2023
Q2
$3.79K Sell
60
-12,240
-100% -$710K ﹤0.01% 479
2023
Q1
$722K Buy
12,300
+1,000
+9% +$60.7K 0.06% 231
2022
Q4
$697K Buy
+11,300
New +$759K 0.06% 241

Other funds holding HQY

Hillsdale Investment Management's HQY Position: Q4 2024 in Review

Hillsdale Investment Management sold out of HealthEquity (HQY) in Q4 2024, closing a stake of 80 shares — an estimated $6.55K sold.

Hillsdale Investment Management first reported a position in HQY in Q4 2022 and held it in 8 quarters. The position peaked at $722K in Q1 2023. 441 funds tracked by Wall St. Rank hold HQY as of Q4 2024.

  • Hillsdale Investment Management reported no remaining HealthEquity position as of Q4 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 80 HealthEquity shares in Q4 2024, an estimated $6.55K.
  • Hillsdale Investment Management first reported a position in HealthEquity in Q4 2022 and held it in 8 quarters.
  • Hillsdale Investment Management's HealthEquity position peaked at $722K in Q1 2023.
  • 441 funds tracked by Wall St. Rank held HealthEquity as of Q4 2024.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.